Literature DB >> 11113189

Gene disruption of tissue transglutaminase.

V De Laurenzi1, G Melino.   

Abstract

Transglutaminase 2 (TGase 2), or tissue transglutaminase, catalyzes either epsilon-(gamma-glutamyl)lysine or N(1), N(8)-(gamma-glutamyl)spermidine isopeptide bonds. TGase 2 expression has been associated with apoptosis, and it has been proposed that its activation should lead to the irreversible assembly of a cross-linked protein scaffold in dead cells. Thus, TGase 2-catalyzed protein polymerization contributes to the ultrastructural changes typical of dying apoptotic cells; it stabilizes the integrity of the apoptotic cells, preventing the release of harmful intracellular components into the extracellular space and, consequently, inflammation and scar formation. In order to perform a targeted disruption of the enzyme, we prepared a construct deleting part of exons 5 and 6, containing the active site, and intron 5. Complete absence of TGase 2 was demonstrated by reverse transcription-PCR and Western blot analysis. TGase activity measured on liver and thymus extracts showed, however, a minimal residual activity in TGase 2(-/-) mice. PCR analysis of mRNA extracted from the same tissues demonstrated that at least TGase 1 (normally present in the skin) is also expressed in these tissues and contributes to this residual activity. TGase 2(-/-) mice showed no major developmental abnormalities, and histological examination of the major organs appeared normal. Induction of apoptosis ex vivo in TGase 2(-/-) thymocytes (by CD95, dexamethasone, etoposide, and H(2)O(2)) and in vitro on TGase 2(-/-) mouse embryonal fibroblasts (by retinoids, UV, and H(2)O(2)) showed no significant differences. A reduction in cross-linked apoptotic bodies with a modestly increased release of lactate dehydrogenase has been detected in some cases. Together our results show that TGase 2 is not a crucial component of the main pathway of the apoptotic program. It is possible that the residual enzymatic activity, due to TGase 1 or redundancy of other still-unidentified TGases, can compensate for the lack of TGase 2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11113189      PMCID: PMC88788          DOI: 10.1128/MCB.21.1.148-155.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis).

Authors:  M Piacentini; L Fesus; M G Farrace; L Ghibelli; L Piredda; G Melino
Journal:  Eur J Cell Biol       Date:  1991-04       Impact factor: 4.492

2.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

3.  Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action.

Authors:  L Fesus; V Thomazy; F Autuori; M P Ceru; E Tarcsa; M Piacentini
Journal:  FEBS Lett       Date:  1989-03-13       Impact factor: 4.124

4.  Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter.

Authors:  L Nagy; M Saydak; N Shipley; S Lu; J P Basilion; Z H Yan; P Syka; R A Chandraratna; J P Stein; R A Heyman; P J Davies
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

5.  Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis.

Authors:  L Piredda; M G Farrace; M Lo Bello; W Malorni; G Melino; R Petruzzelli; M Piacentini
Journal:  FASEB J       Date:  1999-02       Impact factor: 5.191

6.  Immunohistochemical localization of tissue transglutaminase and Bcl-2 in rat uterine tissues during embryo implantation and post-partum involution.

Authors:  M Piacentini; F Autuori
Journal:  Differentiation       Date:  1994-06       Impact factor: 3.880

7.  Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice.

Authors:  L Piredda; A Amendola; V Colizzi; P J Davies; M G Farrace; M Fraziano; V Gentile; I Uray; M Piacentini; L Fesus
Journal:  Cell Death Differ       Date:  1997-08       Impact factor: 15.828

8.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

9.  Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity.

Authors:  K E Achyuthan; C S Greenberg
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

10.  Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing.

Authors:  E Candi; G Melino; A Lahm; R Ceci; A Rossi; I G Kim; B Ciani; P M Steinert
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

View more
  103 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.

Authors:  Kyle B Johnson; Humphrey Petersen-Jones; Janice M Thompson; Kiyotaka Hitomi; Miho Itoh; Erik N T P Bakker; Gail V W Johnson; Gozde Colak; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

Review 3.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

4.  Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1.

Authors:  Nobuo Kuramoto; Toshihiro Takizawa; Takami Takizawa; Masato Matsuki; Hiroyuki Morioka; John M Robinson; Kiyofumi Yamanishi
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct.

Authors:  Jason D Hoffert; Chung-Lin Chou; Robert A Fenton; Mark A Knepper
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

6.  TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Authors:  Federica Rossin; Valeria Rachela Villella; Manuela D'Eletto; Maria Grazia Farrace; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Luca Occhigrossi; Vittoria Pagliarini; Claudio Sette; Giorgio Cozza; Nikolai A Barlev; Laura Falasca; Gian Maria Fimia; Guido Kroemer; Valeria Raia; Luigi Maiuri; Mauro Piacentini
Journal:  EMBO Rep       Date:  2018-05-11       Impact factor: 8.807

7.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.

Authors:  Ju-Hong Jeon; Kyung-Ho Choi; Sung-Yup Cho; Chai-Wan Kim; Dong-Myung Shin; Joon-Cheol Kwon; Kye-Yong Song; Sang-Chul Park; In-Gyu Kim
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

8.  Role of FcRgamma and factor XIIIA in coated platelet formation.

Authors:  Shawn M Jobe; Lorie Leo; Joshua S Eastvold; Gerhard Dickneite; Timothy L Ratliff; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

9.  Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity.

Authors:  Ben Nicholas; Peter Smethurst; Elisabetta Verderio; Richard Jones; Martin Griffin
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

10.  Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse.

Authors:  Helen Williams; Richard J Pease; Laura M Newell; Paul A Cordell; Robert M Graham; Mark T Kearney; Christopher L Jackson; Peter J Grant
Journal:  Atherosclerosis       Date:  2009-11-20       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.